Nrf2 signaling inhibits mediators like cyclooxygenase (COX-2) and inducible nitric oxide synthase (iNOS), which are critical for reducing inflammation and preventing conditions such as arthritis, epithelial neoplasms, and musculoskeletal disorders. This evidence concerns the gene NOS2 and arthritic joint disease.